Acetazolamide prevents hypoxia‐induced reactive oxygen species generation and calcium release in pulmonary arterial smooth muscle
Open Access
- 1 October 2021
- journal article
- research article
- Published by Wiley in Pulmonary Circulation
- Vol. 11 (4) , 1-12
Abstract
Upon sensing a reduction in local oxygen partial pressure, pulmonary vessels constrict, a phenomenon known as hypoxic pulmonary vasoconstriction. Excessive hypoxic pulmonary vasoconstriction can occur with ascent to high altitude and is a contributing factor to the development of high‐altitude pulmonary edema. The carbonic anhydrase inhibitor, acetazolamide, attenuates hypoxic pulmonary vasoconstriction through stimulation of alveolar ventilation via modulation of acid–base homeostasis and by direct effects on pulmonary vascular smooth muscle. In pulmonary arterial smooth muscle cells (PASMCs), acetazolamide prevents hypoxia‐induced increases in intracellular calcium concentration ([Ca2+]i), although the exact mechanism by which this occurs is unknown. In this study, we explored the effect of acetazolamide on various calcium‐handling pathways in PASMCs. Using fluorescent microscopy, we tested whether acetazolamide directly inhibited store‐operated calcium entry or calcium release from the sarcoplasmic reticulum, two well‐documented sources of hypoxia‐induced increases in [Ca2+]i in PASMCs. Acetazolamide had no effect on calcium entry stimulated by store‐depletion, nor on calcium release from the sarcoplasmic reticulum induced by either phenylephrine to activate inositol triphosphate receptors or caffeine to activate ryanodine receptors. In contrast, acetazolamide completely prevented Ca2+‐release from the sarcoplasmic reticulum induced by hypoxia (4% O2). Since these results suggest the acetazolamide interferes with a mechanism upstream of the inositol triphosphate and ryanodine receptors, we also determined whether acetazolamide might prevent hypoxia‐induced changes in reactive oxygen species production. Using roGFP, a ratiometric reactive oxygen species‐sensitive fluorescent probe, we found that hypoxia caused a significant increase in reactive oxygen species in PASMCs that was prevented by 100 μM acetazolamide. Together, these results suggest that acetazolamide prevents hypoxia‐induced changes in [Ca2+]i by attenuating reactive oxygen species production and subsequent activation of Ca2+‐release from sarcoplasmic reticulum stores.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (K08 HL132055, R01 HL067191, R01 HL073859)
- National Heart, Lung, and Blood Institute (K08 HL132055, R01 HL067191, R01 HL073859)
This publication has 71 references indexed in Scilit:
- Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstrictionCell Calcium, 2012
- Primary role of mitochondrial Rieske iron–sulfur protein in hypoxic ROS production in pulmonary artery myocytesFree Radical Biology and Medicine, 2011
- Hypoxia Increases ROS Signaling and Cytosolic Ca 2+ in Pulmonary Artery Smooth Muscle Cells of Mouse Lungs SlicesAntioxidants & Redox Signaling, 2010
- Hypoxia Triggers Subcellular Compartmental Redox Signaling in Vascular Smooth Muscle CellsCirculation Research, 2010
- Evaluation of new thiadiazoles and benzothiazoles as potential radioprotectors: Free radical scavenging activity in vitro and theoretical studies (QSAR, DFT)Free Radical Biology and Medicine, 2009
- Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCɛ signaling axis in pulmonary artery smooth muscle cellsFree Radical Biology and Medicine, 2008
- Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Role of mitochondrial reactive oxygen species in hypoxia-dependent increase in intracellular calcium in pulmonary artery myocytesFree Radical Biology and Medicine, 2007
- Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchangeProceedings of the National Academy of Sciences, 2006
- Inhibition of Hypoxic Pulmonary Vasoconstriction by NifedipineNew England Journal of Medicine, 1981